Literature DB >> 11105930

The economics of creating a positron emission tomography center.

R J Lissak1.   

Abstract

Positron emission tomography (PET) scanning has been a powerful research tool since its inception. Changes in the marketplace that have allowed PET to move into the clinical environment include the commercial availability of appropriate radiopharmaceuticals, reimbursement of procedures by insurance companies, and increasing awareness of physicians of the benefits of PET. Facilities that are interested in clinical PET need to develop a process to purchase equipment with an appropriate business plan. This is necessary to assure financial viability and to convince hospital administrators of the viability. The creation of a successful PET program requires an understanding of all aspects relating to a center. The process begins with reviewing the mission statement of the facility. The next step is to prepare the feasibility study, which includes reviewing the existing marketplace and determining the volume, level of referring physicians' interest, and availability of radiopharmaceuticals. Finally, an appropriate pro forma needs to be constructed to facilitate the final decision concerning the potential financial viability of such an endeavor.

Mesh:

Year:  2000        PMID: 11105930     DOI: 10.1053/snuc.2000.9544

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  2 in total

1.  Activity-based costing evaluation of [18F]-fludeoxyglucose production.

Authors:  Bruno Krug; Annie Van Zanten; Anne-Sophie Pirson; Ralph Crott; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-21       Impact factor: 9.236

2.  Addressing Global Inequities in Positron Emission Tomography-Computed Tomography (PET-CT) for Cancer Management: A Statistical Model to Guide Strategic Planning.

Authors:  Miguel Gallach; Miriam Mikhail Lette; May Abdel-Wahab; Francesco Giammarile; Olivier Pellet; Diana Paez
Journal:  Med Sci Monit       Date:  2020-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.